DROSPIRENONE AND ETHINYL ESTRADIOL (drospirenone and ethinyl estradiol) by Teva is ovulation. Approved for symptoms of premenstrual dysphoric disorder (pmdd) in females of reproductive potential, moderate acne vulgaris in women at least 14 years of age, anxiety and 2 more indications. First approved in 2011.
Drug data last refreshed 19h ago
ovulation.
Worked on DROSPIRENONE AND ETHINYL ESTRADIOL at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants
Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS